Metabolic signatures of human Alzheimer's disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue

Metabolomics

Volumn 10, Issue 4, 2014, Pages 744-753

  Graham, Stewart F ^a   Holscher, Christian ^b   Green, Brian D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Brain; Clinical; Human; Metabolomics; NMR

Indexed keywords

ACETIC ACID; ALANINE; ASPARTIC ACID; CARNITINE; CHOLINE; CREATINE; ETHANOLAMINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HYPOTAURINE; HYPOXANTHINE; INOSINE; INOSITOL; ISOLEUCINE; LACTIC ACID; LEUCINE; N ACETYLASPARTIC ACID; NICOTINIC ACID; PHENYLALANINE; SERINE; SUCCINIC ACID; TAURINE; TYROSINE; VALINE;

AGED; ALZHEIMER DISEASE; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; METABOLITE; METABOLOME; METABOLOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

ANIMALIA;

EID: 84904390828     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0610-1     Document Type: Article

References (28)

1. Banerjee, R., Vitvitsky, V., & Garg, S. K. (2008). The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends in Biochemical Sciences, 33, 413-419.
2. Bozek, K. (2013). Large scale survey of metabolite concentrations in human, chimpanzee, macaque and mouse tissues. Metabolomics,. doi: 10. 4172/2153-0769. S1. 022.
3. Burg, M. B., Kwon, E. D., & Kultz, D. (1997). Regulation of gene expression by hypertonicity. Annual Review of Physiology, 59, 437-455.
4. Cui, Q., Lewis, I. A., Hegeman, A. D., Anderson, M. E., Li, J., Schulte, C. F., et al. (2008). Metabolite identification via the Madison Metabolomics Consortium Database. Nature Biotechnology, 26(2), 162-164.
5. Degeoglu, A., Choi, J. K., Cormier, K., Kowall, N. W., & Jenkins, B. G. (2004). Magnetic resonance spectrometric analysis of Alzheimer's disease mouse brain that expresses mutant human APP shows altered neurochemical profile. Brain Research, 1012(1-2), 60-65.
6. El Idrissi, A., & Trenkner, E. (2004). Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochemical Research, 29, 189-197.
7. Graham, S. F., Chevallier, O., Roberts, D., Elliott, C., & Green, B. (2013a). Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease. Analytical Chemistry, 85(3), 1803-1811.
8. Graham, S. F., Holscher, C., McClean, P., Elliott, C., & Green, B. (2013b). Brain tissue and plasma used to metabolically phenotype Alzheimer's disease in APP/PS1 mice. Metabolomics, 9(5), 974-983.
9. Hagar, H. H. (2004). The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicology Letters, 151, 335-343.
10. Hu, Z. P., Browne, E. R., Liu, T., Angel, T. E., Ho, P. C., & Chan, E. C. (2012). Metabonomic profiling of TAS TPM transgenic Alzheimer's disease model. Journal of Proteome Research, 11(12), 5903-5913.
11. Huxtable, R. J. (1989). Taurine in the central nervous system and the mammalian actions of taurine. Progress in Neurobiology, 32, 471-533.
12. Knight, W. D., Okello, A. A., Ryan, N. S., et al. (2011). Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain, 134, 293-300.
13. Kuriyama, K. (1980). Taurine as a neuromodulator. Federation Proceedings, 39, 2680-2684.
14. Marjanska, M., Curran, G. L., Wendenack, T. M., et al. (2005). Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance. Proceedings of the National Academic of Sciences of USA, 102(33), 11906-11910.
15. Menzie, J., Prentice, H., & Wu, J. Y. (2013). Neuroprotective mechanisms of taurine against ischemic stroke. Brain Science, 3, 877-907.
16. Miao, J., Zhang, J., Zheng, L., Yu, X., Zhu, W., & Zou, S. (2012). Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells. Amino Acids, 42, 2417-2428.
17. Monge-Argiles, J. A., Munoz-Ruiz, C., Pampliega-Perez, A., et al. (2011). Biomarkers of Alzheimer's disease in the cerebrospinal fluid of Spanish patients with mild cognitive impairment. Neurochemical Research, 36, 986-993.
18. Salek, R. M., Xia, J., Innes, A., et al. (2010). A metabolomic study of CRND8 transgenic mouse model of Alzheimer's disease. Neurochemistry International, 56, 937-947.
19. Schaffer, S. W., Azuma, J., & Mozaffari, M. (2009). Role of antioxidant activity of taurine in diabetes. Canadian Journal of Physiology and Pharmacology, 87, 91-99.
20. Sun, M., Zhao, Y., Gu, Y., & Xu, C. (2012). Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. Amino Acids, 42, 1735-1747.
21. Trushina, E., Nemutlu, E., Zhang, S., Christensen, T., Camp, J., et al. (2012). Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of Familial Alzheimer's Disease. Public Library of Science, 7(2), e32737. doi: 10. 1371/journal. pone. 0032737.
22. von Kienlin, M., Kunnecke, B., Metzger, F., et al. (2005). Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiology of Diseases, 18(1), 32-39.
23. Walker, L. C., Diamond, M. I., Duff, K. E., & Hyman, B. T. (2013). Mechanisms of protein seeding in neurodegenerative diseases. American Medical Association, 70(3), 304-310.
24. Wishart, D. S., Jewison, T., Guo, A. C., et al. (2013). The Human metabolome database in 2013. Nucleic Acids Research, 1(41), D801-D807.
25. Wu, H., Jin, Y., Wei, J., et al. (2005). Mode of action of taurine as a neuroprotector. Brain Research, 2005(1038), 123-131.
26. Xia, J., Broadhurst, D. I., Wilson, M., & Wishart, D. S. (2013). Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics, 9, 280-299.
27. Xia, J., Mandal, R., Sinelnikov, I., Broadhurst, D., & Wishart, D. S. (2012). MetaboAnalyst 2. 0-A comprehensive server for metabolomic data analysis. Nucleic Acids Research,. doi: 10. 1093/nar/gks374.
28. Xia, J., Psychogios, N., Young, N., & Wishart, D. S. (2009). MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Research, 37, W652-W660.